
A pioneer at heart
Shinsuke Muto’s vision for Japan.

Family ties
Living with a genetic disease.

No participant left behind
Caring for patients.

A life-changing encounter
A film reportage.

A life-changing encounter
The making of a rare disease drug.

The Beacons
Never alone.

Following a blood line
Never give up.

In Colombia, a researcher works against a devastating disease
Pure willpower.

Transcript - Turning a loss into a superpower
An empowering impairment.

House of memory
Taking care of dementia patients.

Caring for Mother
Life as a caregiver.

Chain reaction
Following the path of a medicine.

House of memories
The tragedy of Alzheimer’s disease.

Two worlds one goal
Pioneer of gene therapy.

Fighting fake medicines
Detecting fake drugs.

Spooky Times
A city in lockdown.

A life with chronic joint inflammation
Relieve pain and delay the progression of the disease.

Living with cancer
Timely support.

«A blessing in disguise»
Living with age-related macular degeneration.

Always on the move
On the move for physicians and patients.
Shorts
Our stories in shortform

Browse back issues
Download past issues of liv magazine.
Access to downloadable PDFs
Live Magazine – Science, made human
Discover the story behind Live Magazine, Novartis’ global publication launched in 1996 and now available in four languages. Explore how it evolved into a digital platform in 2020, sharing insights and innovations from across the company.
Learn more
About live magazine
Live magazine has been the in-house magazine of Novartis since 1996. It is available to the general public since 2020.
Associates/Pensioners
Associates in Switzerland and pensioners can receive the Forum supplement with birthday and other data via email. Please write to live.magazine@novartis.com, providing your name and personnel number.
Get our Updates
Stay connected by subscribing to our newsletter
By submitting your email, you consent to Novartis AG collecting and processing your email data for Novartis internal use, in accordance with our privacy policy, and by protected technical means.






























